Acute promyelocytic leukemia (APL) is a type of acute myeloid leukemia (AML). With proper treatment, the survival rates are high. APL is a relatively rare cancer, accounting for about 7–8% of ...

Acute myelogenous leukemia, or AML, remains one of the most aggressive blood cancers. Each year, around 44,000 people in the ...

Knowing whether you have this fusion can also help your specialist decide on the best treatment for you. APL can develop very quickly so you will start treatment straight away usually before all of ...

The interim analysis results of the Phase II clinical trial showed that in the APL-1202 and tislelizumab combination treatment group, out of 18 subjects evaluated, 7 achieved pCR, accounting for 7 ...

A dog rescued by the Ashtabula County Animal Protective League on Friday is receiving treatment. APL Executive Director Catena Shore said the APL received humane complaint the same day they sent their ...

Additionally, the study found that at 6 months after the first treatment, the regression rate (RR) in the APL-1702 group was significantly higher than that in the placebo group (47.0% vs.

Hematologists need to thoroughly understand these fine morphologic details unique to APL as it requires prompt treatment once suspected. APL is treatable with the help of therapy targeted at the ...